Lead Medical Science Liaison, Molecular Imaging (Northeast)

Lead Medical Science Liaison, Molecular Imaging (Northeast)At Bayer we're visionaries, driven to solve the world's toughest challenges and striving for a world where 'Health for all Hunger for none' is no longer a dream, but a real possibility. We're doing it with energy, curiosity and sheer dedication, always learning from unique perspectives of those around us, expanding our thinking, growing our capabilities and redefining 'impossible'.The Lead Medical Science Liaison (MSL) is responsible for providing scientific and objective medical information to healthcare providers and researchers in therapeutic areas of interest to Molecular Imaging within Bayer Radiology. The MSL is responsible for developing and executing clinical/medical education strategies and providing training via in person, virtual and hybrid environments, serves as medical and scientific support in the field for healthcare providers ensuring safe and effective use of Bayer products including timely adverse event reporting and responses to unsolicited requests for detailed product, and disease state information.The MSL will also collaborate with internal business partners as an expert consultant to meet specific scientific needs of internal and external contacts within specific therapeutic and geographic areas and will represent the company at scientific conferences, symposiums, and medical meetings.Your Tasks and ResponsibilitiesThe primary responsibilities of this role, Lead Medical Science Liaison, Molecular Imaging (Northeast), are to:Maintenance of Scientific ExpertiseDirect scientific exchangeThought Leader EngagementIn additionWho You AreBayer seeks an incumbent who possesses the following:Required Qualifications:Preferred Qualifications:Employees can expect to be paid a salary of between $168,500 to $252,800. Additional compensation may include a bonus or commission (if relevant). Additional benefits include health care, vision, dental, retirement, PTO, sick leave, etc.This posting will be available for application until at least: June 16, 2026.